Standard Chemical & Pharmaceutical Co Ltd Market Cap ($319.22 Million)
Market Cap & Net Worth: Standard Chemical & Pharmaceutical Co Ltd (1720)
Standard Chemical & Pharmaceutical Co Ltd market cap. Standard Chemical & Pharmaceutical Co Ltd (TW:1720) has a market capitalization of $319.22 Million (NT$10.13 Billion) as of November 1, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #14215 globally and #601 in its home market, demonstrating a -0.18% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Standard Chemical & Pharmaceutical Co Ltd's stock price NT$56.70 by its total outstanding shares 178696000 (178.70 Million). Also see 1720 cash flow conversion for how efficiently the company converts equity into cash flow.
Standard Chemical & Pharmaceutical Co Ltd Market Cap History (2015–2026)
Standard Chemical & Pharmaceutical Co Ltd market cap history from 2015 to 2026. Data shows growth from $154.88 Million to $319.22 Million (8.52% CAGR). Check Standard Chemical & Pharmaceutical Co Lt stock price for real-time trading data and today's change.
Standard Chemical & Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Standard Chemical & Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Standard Chemical & Pharmaceutical Co Lt annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.05x
Standard Chemical & Pharmaceutical Co Ltd's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.40x
Standard Chemical & Pharmaceutical Co Ltd's market cap is 0.40 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $154.88 Million | $3.32 Billion | $347.89 Million | 0.05x | 0.45x |
| 2016 | $135.75 Million | $3.67 Billion | $340.22 Million | 0.04x | 0.40x |
| 2017 | $154.05 Million | $3.85 Billion | $363.29 Million | 0.04x | 0.42x |
| 2018 | $141.72 Million | $3.57 Billion | $374.36 Million | 0.04x | 0.38x |
| 2019 | $158.71 Million | $3.94 Billion | $376.48 Million | 0.04x | 0.42x |
| 2020 | $183.98 Million | $4.31 Billion | $524.17 Million | 0.04x | 0.35x |
| 2021 | $220.30 Million | $4.60 Billion | $706.73 Million | 0.05x | 0.31x |
| 2022 | $332.05 Million | $5.85 Billion | $1.15 Billion | 0.06x | 0.29x |
| 2023 | $371.01 Million | $6.24 Billion | $834.89 Million | 0.06x | 0.44x |
| 2024 | $348.49 Million | $6.79 Billion | $880.50 Million | 0.05x | 0.40x |
Competitor Companies of 1720 by Market Capitalization
Companies near Standard Chemical & Pharmaceutical Co Ltd in the global market cap rankings as of November 1, 2026. Also see how large is Standard Chemical & Pharmaceutical Co Lt's balance sheet for a full breakdown of the balance sheet.
Key companies related to Standard Chemical & Pharmaceutical Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Standard Chemical & Pharmaceutical Co Ltd (2015–2026)
Market capitalization of Standard Chemical & Pharmaceutical Co Ltd from 2015 to today. Between 2015 and today, Standard Chemical & Pharmaceutical Co Ltd's market cap moved from $154.88 Million to $ 319.22 Million, with a yearly change of 8.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$319.22 Million | -3.74% |
| 2025 | NT$331.60 Million | -4.85% |
| 2024 | NT$348.49 Million | -6.07% |
| 2023 | NT$371.01 Million | +11.73% |
| 2022 | NT$332.05 Million | +50.73% |
| 2021 | NT$220.30 Million | +19.74% |
| 2020 | NT$183.98 Million | +15.93% |
| 2019 | NT$158.71 Million | +11.98% |
| 2018 | NT$141.72 Million | -8.00% |
| 2017 | NT$154.05 Million | +13.48% |
| 2016 | NT$135.75 Million | -12.35% |
| 2015 | NT$154.88 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Standard Chemical & Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $319.22 Million USD |
| MoneyControl | $319.22 Million USD |
| MarketWatch | $319.22 Million USD |
| marketcap.company | $319.22 Million USD |
| Reuters | $319.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Standard Chemical & Pharmaceutical Co Ltd
Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicine, cosmetics, beverage, normal instruments, and medical instruments. It also sells various medical supplements, as well as preventive medicine; and imports and exports various medical products, med… Read more